It is worth noting that increased GluA1 expression and phosphorylation are common phenomena that happen during schizophrenia, depression, Alzheimer's disease, and chronic drug addiction (Sathler et al., 2021; Zhang & Abdullah, 2013). This evidence concerns the gene GRIA1 and depressive symptom measurement.